Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Nov 19, 2021
Date Accepted: Mar 1, 2023

The final, peer-reviewed published version of this preprint can be found here:

A Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Study

Vlasakova M, Muzik J, Holubová A, Fiala D, Arsand E, Urbanová J, Janíčková Žďárská D, Brabec M, Brož J

A Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Study

JMIR Form Res 2023;7:e35064

DOI: 10.2196/35064

PMID: 37115601

PMCID: 10182449

Telemonitoring system Diani intervention in patients with type 1 diabetes: feasibility study

  • Martina Vlasakova; 
  • Jan Muzik; 
  • Anna Holubová; 
  • Dominik Fiala; 
  • Eirik Arsand; 
  • Jana Urbanová; 
  • Denisa Janíčková Žďárská; 
  • Marek Brabec; 
  • Jan Brož

ABSTRACT

Background:

The objective of the study was to evaluate the benefits of the telemedicine system (Diani) for the treatment of type 1 diabetes patients.

Objective:

The objective of the study was to evaluate the benefits of the Diani telemedicine system for the treatment of type 1 diabetes patient. The obtained suggestions will lead to further verification and development of the system in order to better compensate for diabetes mellitus.

Methods:

Data were obtained from a 24-week feasibility study. Patients responded to the standardized WHOQOL-BREF quality of life questionnaire and the system evaluation questionnaire. The level of glycated hemoglobin and the patient's weight were examined, the patient's usage of the telemedicine system was monitored, and daily physical activity was measured. All data were being sent from the patient-device to the Diani server using a real-time diabetes diary application. Wilcoxon and Friedman tests and LME method were used for data analysis. This study involved 10 patients (5 men and 5 women), with a mean age of 47.7 ± 19.3 years; the mean duration of diabetes was 10.5 ± 8.6 years; and the mean HbA1c was 59.5 ± 6.7 mmol/mol.

Results:

The median number of days the patients tested the system was 84. After the intervention the mean HbA1c decreased by 4.35 mmol/mol (p = 0.011). Patients spent 18.6 ± 6.8 minutes on average using the application daily. After the intervention, the number of patients who measured their blood glucose at least 3 times a day increased by 30%. The graphical display of measured parameters, automatic transmission of measured data from the glucometer, compatibility and interconnection of individual devices when entering data were evaluated by patients in a positive way.

Conclusions:

The Diani system was found to be beneficial for type 1 diabetes mellitus patients in terms of managing their disease. Patients perceived it positively; it strengthened their education in the field of diabetes and understanding the influence of measured values for the management of their disease. Its use had a positive effect on the HbA1C level.


 Citation

Please cite as:

Vlasakova M, Muzik J, Holubová A, Fiala D, Arsand E, Urbanová J, Janíčková Žďárská D, Brabec M, Brož J

A Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Study

JMIR Form Res 2023;7:e35064

DOI: 10.2196/35064

PMID: 37115601

PMCID: 10182449

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.